A PI3K pathway mediates hair cell survival and opposes gentamicin toxicity in neonatal rat organ of Corti

被引:58
|
作者
Chung, Won-Ho
Pak, Kwang
Lin, Bo
Webster, Nicholas
Ryan, Allen F.
机构
[1] Univ Calif San Diego, Sch Med, Dept Surg Otolaryngol, ENT 0666, La Jolla, CA 92093 USA
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otolaryngol, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Head & Neck Surg, Seoul 135710, South Korea
[4] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA
[5] VA Med Ctr, La Jolla, CA 92093 USA
[6] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA
[7] VA Med Ctr, La Jolla, CA USA
来源
JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY | 2006年 / 7卷 / 04期
关键词
gentamicin; hair cell; ototoxicity; PI3K; PKC; PKB; Akt; PLC gamma;
D O I
10.1007/s10162-006-0050-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Gentamicin is well known to promote hair cell death in inner ear, but it also appears to activate opposing pathways that promote hair cell survival. In combination with others, our previous work has indicated that a K-Ras/Rac/JNK pathway is important for hair cell death and an H-Ras/Raf/MEK/Erk pathway is involved in promoting hair cell survival (Battaglia et al., Neuroscience 122(4):1025-1035, 2003). However, these data also suggested that a Ras-independent survival pathway for activation of MEK might be stimulated by gentamicin. To investigate alternatives to the Ras/Raf/MEK/Erk pathway in promoting hair cell survival, cochlear explants were exposed to gentamicin combined with several inhibitors of alternative pathways (LY294002, calphostin C, SH-6, U73122). When exposed to gentamicin with the PI3K inhibitor LY294002 (10, 50 mu M), the protein kinase C (PKC) inhibitor calphostin C (50, 100 nM) or the PKB/Akt inhibitor SH-6 (5, 10 mu M), hair cell damage was significantly increased compared to gentamicin alone. By Western blotting, strong PKB/Akt activation was observed in the organ of Corti following exposure to 50 mu M gentamicin for 6 h. In addition, PKC activation by 12-O-tetradecanoylphorbol-13-acetate protected outer hair cells from gentamicin induced cell death. In contrast, the phospholipase C-gamma (PLC gamma) inhibitor U73122 (2, 5 mu M) did not affect hair cell damage when combined with gentamicin. Also, phosphorylation of PLC gamma was not increased in the organ of Corti following gentamicin treatment, as evaluated by Western blot. The results indicate that PI3K promotes hair cell survival via its downstream targets, PKC and PKB/Akt. This suggests that both Ras-dependent and Ras-independent survival pathways are involved during gentamicin exposure. In contrast, PLC gamma activation of PKC does not appear to play a role.
引用
收藏
页码:373 / 382
页数:10
相关论文
共 50 条
  • [21] PI3K/Akt/mTOR, a Pathway Less Recognized for Staphylococcal Superantigen-Induced Toxicity
    Krakauer, Teresa
    TOXINS, 2012, 4 (11): : 1343 - 1366
  • [22] PI3K/AKT signaling pathway activation in a rat model of migraine
    Liu, Yun-Yong
    Jiao, Zi-Yao
    Li, Wei
    Tian, Qian
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 4849 - 4854
  • [23] Relationship between PI3K pathway and angiogenesis in CIA rat synovium
    Zou, Lin
    Zhang, Guichun
    Liu, Lifeng
    Chen, Chen
    Cao, Xuecheng
    Cai, Jinfang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (07): : 3141 - 3147
  • [24] Downregulation of the PI3K/Akt survival pathway in cells with deregulated expression of c-Myc
    Bellmann, Kerstin
    Martel, Julie
    Poirier, Dominic J. P.
    Labrie, Mireille M.
    Landry, Jacques
    APOPTOSIS, 2006, 11 (08) : 1311 - 1319
  • [25] Activation of the PI3K/Akt Pathway by Oxidative Stress Mediates High Glucose-Induced Increase of Adipogenic Differentiation in Primary Rat Osteoblasts
    Zhang, Yu
    Yang, Jian-Hong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (11) : 2595 - 2602
  • [26] Does the PI3K pathway promote or antagonize regulatory T cell development and function?
    Soond, Dalya R.
    Slack, Elizabeth C. M.
    Garden, Oliver A.
    Patton, Daniel T.
    Okkenhaug, Klaus
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [27] Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
    Fumarola, Claudia
    Bonelli, Mara A.
    Petronini, Pier Giorgio
    Alfieri, Roberta R.
    BIOCHEMICAL PHARMACOLOGY, 2014, 90 (03) : 197 - 207
  • [28] The PI3K/Akt pathway is not a main driver in HDL-mediated cell protection
    Zheng, Adi
    Dubuis, Gilles
    Ferreira, Carla Susana Mendes
    Petremand, Jannick
    Vanli, Gueliz
    Widmann, Christian
    CELLULAR SIGNALLING, 2019, 62
  • [29] PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway
    Hai-ping Zhang
    Zi-liang Yu
    Bing-bing Wu
    Fa-rui Sun
    Journal of Orthopaedic Surgery and Research, 15
  • [30] PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway
    Zhang, Hai-ping
    Yu, Zi-liang
    Wu, Bing-bing
    Sun, Fa-rui
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2020, 15 (01)